BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yong SB, Song Y, Kim HJ, Ain QU, Kim YH. Mononuclear phagocytes as a target, not a barrier, for drug delivery. J Control Release 2017;259:53-61. [PMID: 28108325 DOI: 10.1016/j.jconrel.2017.01.024] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Yin Y, Han X, Li C, Sun T, Li K, Liu X, Liu M. The status of industrialization and development of exosomes as a drug delivery system: A review. Front Pharmacol 2022;13:961127. [DOI: 10.3389/fphar.2022.961127] [Reference Citation Analysis]
2 Wan Z, Gan X, Mei R, Du J, Fan W, Wei M, Yang G, Qin W, Zhu Z, Liu L. ROS triggered local delivery of stealth exosomes to tumors for enhanced chemo/photodynamic therapy. J Nanobiotechnology 2022;20:385. [PMID: 35999549 DOI: 10.1186/s12951-022-01591-7] [Reference Citation Analysis]
3 Al-Ogaidi I, Aguilar ZP, Lay JO Jr. Development of Biodegradable/Biocompatible Nanoliposome-Encapsulated Antimicrobial Essential Oils for Topical Creams and Gels. ACS Omega 2022;7:23875-89. [PMID: 35847299 DOI: 10.1021/acsomega.2c02594] [Reference Citation Analysis]
4 Ben X, Wang Y, Zheng H, Li D, Ren R, Ni P, Zhang H, Feng R, Li Y, Li Q, Yi X. Construction of Exosomes that Overexpress CD47 and Evaluation of Their Immune Escape. Front Bioeng Biotechnol 2022;10:936951. [DOI: 10.3389/fbioe.2022.936951] [Reference Citation Analysis]
5 Shi J, Huang MW, Lu ZD, Du XJ, Shen S, Xu CF, Wang J. Delivery of mRNA for regulating functions of immune cells. J Control Release 2022:S0168-3659(22)00159-6. [PMID: 35337940 DOI: 10.1016/j.jconrel.2022.03.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Hunt NJ, Mccourt PAG, Kuncic Z, Le Couteur DG, Cogger VC. Opportunities and Challenges for Nanotherapeutics for the Aging Population. Front Nanotechnol 2022;4:832524. [DOI: 10.3389/fnano.2022.832524] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Ding X, Sun X, Cai H, Wu L, Liu Y, Zhao Y, Zhou D, Yu G, Zhou X. Engineering Macrophages via Nanotechnology and Genetic Manipulation for Cancer Therapy. Front Oncol 2021;11:786913. [PMID: 35070992 DOI: 10.3389/fonc.2021.786913] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Cherne MD, Sidar B, Sebrell TA, Sanchez HS, Heaton K, Kassama FJ, Roe MM, Gentry AB, Chang CB, Walk ST, Jutila M, Wilking JN, Bimczok D. A Synthetic Hydrogel, VitroGel® ORGANOID-3, Improves Immune Cell-Epithelial Interactions in a Tissue Chip Co-Culture Model of Human Gastric Organoids and Dendritic Cells. Front Pharmacol 2021;12:707891. [PMID: 34552484 DOI: 10.3389/fphar.2021.707891] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
9 Du J, Wan Z, Wang C, Lu F, Wei M, Wang D, Hao Q. Designer exosomes for targeted and efficient ferroptosis induction in cancer via chemo-photodynamic therapy. Theranostics 2021;11:8185-96. [PMID: 34373736 DOI: 10.7150/thno.59121] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 14.0] [Reference Citation Analysis]
10 Wei Z, Chen Z, Zhao Y, Fan F, Xiong W, Song S, Yin Y, Hu J, Yang K, Yang L, Xu B, Ge J. Mononuclear phagocyte system blockade using extracellular vesicles modified with CD47 on membrane surface for myocardial infarction reperfusion injury treatment. Biomaterials 2021;275:121000. [PMID: 34218049 DOI: 10.1016/j.biomaterials.2021.121000] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
11 Deng Y, Zhou Y, Liang Q, Ge C, Yang J, Shan B, Liu Y, Zhou X, Yin L. Inflammation‐Instructed Hierarchical Delivery of IL‐4/miR‐21 Orchestrates Osteoimmune Microenvironment toward the Treatment of Rheumatoid Arthritis. Adv Funct Materials 2021;31:2101033. [DOI: 10.1002/adfm.202101033] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
12 Gao X, Ding J, Long Q, Zhan C. Virus-mimetic systems for cancer diagnosis and therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;13:e1692. [PMID: 33354937 DOI: 10.1002/wnan.1692] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Van Hees S, Elbrink K, De Schryver M, Delputte PL, Kiekens F. Improving cellular uptake and cytotoxicity of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles in macrophages. Nanomedicine (Lond) 2020;15:2671-88. [PMID: 33112210 DOI: 10.2217/nnm-2020-0317] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
14 DeVallance E, Li Y, Jurczak MJ, Cifuentes-Pagano E, Pagano PJ. The Role of NADPH Oxidases in the Etiology of Obesity and Metabolic Syndrome: Contribution of Individual Isoforms and Cell Biology. Antioxid Redox Signal 2019;31:687-709. [PMID: 31250671 DOI: 10.1089/ars.2018.7674] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
15 Azarmi M, Maleki H, Nikkam N, Malekinejad H. Transcellular brain drug delivery: A review on recent advancements. International Journal of Pharmaceutics 2020;586:119582. [DOI: 10.1016/j.ijpharm.2020.119582] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
16 Yong SB, Kim J, Chung JY, Ra S, Kim SS, Kim YH. Heme Oxygenase 1-Targeted Hybrid Nanoparticle for Chemo- and Immuno-Combination Therapy in Acute Myelogenous Leukemia. Adv Sci (Weinh) 2020;7:2000487. [PMID: 32670766 DOI: 10.1002/advs.202000487] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
17 Wan Z, Zhao L, Lu F, Gao X, Dong Y, Zhao Y, Wei M, Yang G, Xing C, Liu L. Mononuclear phagocyte system blockade improves therapeutic exosome delivery to the myocardium. Theranostics 2020;10:218-30. [PMID: 31903116 DOI: 10.7150/thno.38198] [Cited by in Crossref: 62] [Cited by in F6Publishing: 71] [Article Influence: 20.7] [Reference Citation Analysis]
18 Kim H, Han J, Park J. Cyclodextrin polymer improves atherosclerosis therapy and reduces ototoxicity. Journal of Controlled Release 2020;319:77-86. [DOI: 10.1016/j.jconrel.2019.12.021] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
19 Ding J, Zhao D, Hu Y, Liu M, Liao X, Zhao B, Liu X, Deng Y, Song Y. Terminating the renewal of tumor-associated macrophages: A sialic acid-based targeted delivery strategy for cancer immunotherapy. International Journal of Pharmaceutics 2019;571:118706. [DOI: 10.1016/j.ijpharm.2019.118706] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
20 de la Harpe KM, Kondiah PPD, Choonara YE, Marimuthu T, du Toit LC, Pillay V. The Hemocompatibility of Nanoparticles: A Review of Cell-Nanoparticle Interactions and Hemostasis. Cells 2019;8:E1209. [PMID: 31591302 DOI: 10.3390/cells8101209] [Cited by in Crossref: 112] [Cited by in F6Publishing: 120] [Article Influence: 28.0] [Reference Citation Analysis]
21 Shamsi M, Mohammadi A, Manshadi MK, Sanati-nezhad A. Mathematical and computational modeling of nano-engineered drug delivery systems. Journal of Controlled Release 2019;307:150-65. [DOI: 10.1016/j.jconrel.2019.06.014] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
22 Granot-matok Y, Kon E, Dammes N, Mechtinger G, Peer D. Therapeutic mRNA delivery to leukocytes. Journal of Controlled Release 2019;305:165-75. [DOI: 10.1016/j.jconrel.2019.05.032] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
23 Yuan Y, Liu S, Zhao Y, Lian L, Lian Z. Interferon-γ acts as a regulator in the trade-off between phagocytosis and production performance in dwarf chickens. J Anim Sci Biotechnol 2018;9:40. [PMID: 29796253 DOI: 10.1186/s40104-018-0256-y] [Reference Citation Analysis]
24 Zheng M, Tao W, Zou Y, Farokhzad OC, Shi B. Nanotechnology-Based Strategies for siRNA Brain Delivery for Disease Therapy. Trends Biotechnol 2018;36:562-75. [PMID: 29422412 DOI: 10.1016/j.tibtech.2018.01.006] [Cited by in Crossref: 95] [Cited by in F6Publishing: 77] [Article Influence: 19.0] [Reference Citation Analysis]
25 Yong SB, Song Y, Kim YH. Visceral adipose tissue macrophage-targeted TACE silencing to treat obesity-induced type 2 diabetes. Biomaterials 2017;148:81-9. [PMID: 28985514 DOI: 10.1016/j.biomaterials.2017.09.023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
26 Granot Y, Peer D. Delivering the right message: Challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics-An innate immune system standpoint. Semin Immunol 2017;34:68-77. [PMID: 28890238 DOI: 10.1016/j.smim.2017.08.015] [Cited by in Crossref: 61] [Cited by in F6Publishing: 69] [Article Influence: 10.2] [Reference Citation Analysis]